Although further studies are needed to determine the complex dynamics of RB and RAD51 interaction and the time course of recruitment for additional DNA damage response proteins, we have demonstrated here that manipulation of RB expression changes both the radiosensitivity of breast cancer cells and their susceptibility to CDK4/6 inhibitor–mediated suppression of HR. Here, RB1 is linked to breast cancer.